Variation in Definitive Therapy for Localized Non-Small Cell Lung Cancer among National Comprehensive Cancer Network Institutions

International Journal of Radiation Oncology Biology Physics

Volumn 94, Issue 2, 2016, Pages 360-367

  Valle, Luca F ^a   Jagsi, Reshma ^c   Bobiak, Sarah N ^d   Zornosa, Carrie ^d   D'Amico, Thomas A ^e   Pisters, Katherine M ^f   Dexter, Elisabeth U ^g   Niland, Joyce C ^h   Hayman, James A ^c   Kapadia, Nirav S ^b,i  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b NORRIS COTTON CANCER CENTER   (United States)

^c UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^d National Comprehensive Cancer Network   (United States)

^e DUKE CANCER INSTITUTE   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

^h CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

ⁱ DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; BRAIN MAPPING; DECISION MAKING; DISEASES; DRUG PRODUCTS; NEUROIMAGING; RADIOTHERAPY; SOCIETIES AND INSTITUTIONS; SURGERY;

DEFINITIVE THERAPY; METHODS AND MATERIALS; NON SMALL CELL LUNG CANCER; OUTCOME MEASURES; PHYSICIAN PREFERENCES; PRIMARY MODALITY; STEREOTACTIC BODY RT; SURGICAL PATIENTS;

PATIENT TREATMENT;

CIGARETTE SMOKE;

ADULT; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; ENDOBRONCHIAL ULTRASONOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; HEART INFARCTION; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MIDDLE AGED; NON SMALL CELL LUNG CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION INJURY; SQUAMOUS CELL LUNG CARCINOMA; STEREOTACTIC BODY RADIATION THERAPY; ADVERSE EFFECTS; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; DECISION MAKING; LUNG NEOPLASMS; MULTICENTER STUDY; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; SECONDARY; STANDARDS; TRENDS; UTILIZATION;

BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; DECISION MAKING; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEDIASTINOSCOPY; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PRACTICE PATTERNS, PHYSICIANS'; RADIOTHERAPY;

EID: 84953386449     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.10.030     Document Type: Article

References (49)

1. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA Cancer J Clin 65 2015 5 29
2. D. Morgensztern, S. Ng, F. Gao, and et al. Trends in stage distribution for patients with non-small cell lung cancer: A National Cancer Database survey J Thorac Oncol 5 2010 29 33
3. H. Nakamura, N. Kawasaki, M. Taguchi, and et al. Survival following lobectomy vs limited resection for stage I lung cancer: A meta-analysis Br J Cancer 92 2005 1033 1037
4. C. Mery, A. Pappas, R. Bueno, and et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the Surveillance, Epidemiology, and End Results database Chest 128 2005 237 245
5. R. Ginsberg, and L. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 60 1995 615 622
6. D.R. Aberle, A.M. Adams, C.D. Berg, et al. for the National Lung Screening Trial Research Team Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 2011 395 409
7. A. El-Sherif, W. Gooding, R. Santos, and et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: A 13-year analysis Ann Thorac Surg 82 2005 408 415
8. R. Landreneau, D. Sugarbaker, M. Mack, and et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer J Thorac Cardiovasc Surg 113 1997 691 698
9. Altorki N, for the Alliance for Clinical Trials in Oncology. Comparison of different types of surgery in treating patients with stage IA non-small cell lung cancer. NCT00499330. Available at: https://clinicaltrials.gov/ct2/show/NCT00499330. Accessed November 5, 2015.
10. S. Riaz, K. Linklater, R. Page, and et al. Recent trends in resection rates among non-small cell lung cancer patients in England Thorax 67 2012 811 814
11. D. Ettinger, W. Akerly, H. Borghael, et al. for the NCCN (National Comprehensive Cancer Network) Non-small cell lung cancer J Natl Compr Canc Netw 10 2012 1236 1271
12. D. Jaffray, J. Siewerdsen, J. Wong, and et al. Flat-panel cone-beam computed tomography for image-guided radiation therapy Int J Radiat Oncol Biol Phys 53 2002 1337 1349
13. B. Emami, J. Purdy, J. Manolis, and et al. Three dimensional treatment planning for lung cancer Int J Radiat Oncol Biol Phys 21 1991 217 227
14. J. Wong, M. Sharpe, D. Jaffray, and et al. The use of active breathing control (ABC) to reduce margin for breathing motion Int J Radiat Oncol Biol Phys 44 1999 911 919
15. R. Timmerman, R. Paulus, J. Galvin, and et al. Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
16. P. Baumann, J. Nyman, M. Hoyer, and et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
17. T. Crabtree, C. Denlinger, B. Meyers, and et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer J Thorac Cardiovasc Surg 140 2010 377 386
18. I. Grills, V. Mangona, R. Welsh, and et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer J Clin Oncol 28 2010 928 935
19. S. Shirvani, J. Jiang, J. Chang, and et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly Int J Radiat Oncol Biol Phys 84 2012 1060 1070
20. S.M. Shirvani, J. Jiang, J.Y. Chang, and et al. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly JAMA Surg 149 2014 1244 1253
21. American College of Surgeons. Surgery with or without internal radiation therapy compared with stereotactic body radiation therapy in treating patients with high-risk stage I non-small cell lung cancer. NCT01336894. Available at: https://clinicaltrials.gov/ct2/show/NCT01336894. Accessed November 5, 2015.
22. Accuray, Inc. Randomized study to compare CyberKnife to surgical resection in stage I non-small cell lung cancer (STARS). NCT00840749. Available at: https://clinicaltrials.gov/ct2/show/NCT00840749. Accessed November 5, 2015.
23. T. Crabtree, V. Puri, R. Timmerman, and et al. Treatment of stage I lung cancer in high-risk and inoperable patients: Comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033) J Thorac Cardiovasc Surg 145 2013 692 699
24. N.E. Verstegen, J.W. Oosterhuis, D.A. Palma, and et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): Outcomes of a propensity score-matched analysis Ann Oncol 24 2013 1543 1548
25. J.Y. Chang, S. Senan, M.A. Paul, and et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: A pooled analysis of two randomised trials Lancet Oncol 16 2015 630 637
26. J. Wennberg Tracking Medicine: A Researcher's Quest to Understand Health Care 2010 Oxford University Press New York
27. N. Kapadia, R. Mamet, C. Zornosa, and et al. Radiation therapy at the end of life in patients with incurable nonsmall cell lung cancer Cancer 118 2012 4339 4345
28. J.N. Weinstein, K.K. Bronner, T.S. Morgan, and et al. Trends and geographic variations in major surgery for degenerative diseases of the hip, knee, and spine Health Aff (Millwood) Suppl Variation 2004 VAR81 VAR89
29. H. Bilal, S. Mahmood, B. Rajashanker, and et al. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer? Interact Cardiovasc Thorac Surg 15 2012 258 265
30. H. Yamashita, W. Takahashi, A. Haga, and et al. Radiation pneumonitis after stereotactic radiation therapy for lung cancer World J Radiol 6 2014 708 715
31. E. Hyams, P. Goodney, N. Dzebisashvili, and et al. Variation in the Care of Surgical Conditions: Prostate Cancer. A Dartmouth Atlas of Healthcare Series 2014 The Dartmouth Institute of Health Policy & Clinical Practice Lebanon, NH
32. M.E. Daly, J.R. Perks, and A.M. Chen Patterns-of-care for thoracic stereotactic body radiotherapy among practicing radiation oncologists in the United States J Thorac Oncol 8 2013 202 207
33. C.D. Corso, H.S. Park, A.C. Moreno, and et al. Stage I lung SBRT clinical practice patterns [published online December 10, 2014] Am J Clin Oncol 2014
34. F.M. Kong, K.C. Cuneo, L. Wang, and et al. Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation Oncology Pract Radiat Oncol 4 2014 e133 e141
35. H. Pan, D. Simpson, L. Mell, and et al. A survey of stereotactic body radiation therapy use in the United States Cancer 117 2011 4566 4572
36. J.B.S.P. Yu, L.D. Cramer, R.H. Decker, and et al. Diffusion of stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) in the Medicare population, 2007-2009 J Clin Oncol 32 2014
37. D. Palma, O. Visser, F. Lagerwaard, and et al. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: A population-based time-trend analysis J Clin Oncol 28 2010 5153 5159
38. What Makes an NCCN Cancer Center? Available at: http://www.nccn.org/patients/about/member-institutions/qualities.aspx. Accessed May 23, 2015.
39. L.K. Mell, J.C. Roeske, and A.J. Mundt A survey of intensity-modulated radiation therapy use in the United States Cancer 98 2003 204 211
40. Dartmouth Atlas project topic brief: Preference sensitive care. Available at: http://www.dartmouthatlas.org/downloads/reports/preference-sensitive.pdf. Accessed May 23, 2015.
41. K. Baicker, A. Chandra, J.S. Skinner, and et al. Who you are and where you live: How race and geography affect the treatment of medicare beneficiaries Health Aff (Millwood) Suppl Variation 2004 VAR33 VAR44
42. D.S.J. Cutler, A.D. Stern, and D. Wennberg Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending 2013 National Bureau of Economic Research Cambridge, MA
43. A.M. O'Hare, R.A. Rodriguez, S.M. Hailpern, and et al. Regional variation in health care intensity and treatment practices for end-stage renal disease in older adults JAMA 304 2010 180 186
44. K. Antman, D. Amato, W. Wood, and et al. Selection bias in clinical trials J Clin Oncol 3 1985 1142 1147
45. A.V. Louie, S. Senthi, and D.A. Palma Surgery versus SABR for NSCLC Lancet Oncol 14 2013 e491
46. S.R. Wilson, P. Strub, A.S. Buist, and et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma Am J Respir Crit Care Med 181 2010 566 577
47. K.L. Kehl, M. Landrum, N.K. Arora, and et al. Association of actual and preferred decision roles with patient-reported quality of care: Shared decision making in cancer care JAMA Oncol 1 2015 50 58
48. K.R. Sepucha, J.K. Belkora, S. Mutchnick, and et al. Consultation planning to help breast cancer patients prepare for medical consultations: Effect on communication and satisfaction for patients and physicians J Clin Oncol 20 2002 2695 2700
49. K.R. Sepucha, J.K. Belkora, D. Tripathy, and et al. Building bridges between physicians and patients: Results of a pilot study examining new tools for collaborative decision making in breast cancer J Clin Oncol 18 2000 1230 1238